Wild bitter gourd improves metabolic syndrome: A preliminary dietary supplementation trial
Open Access
- 13 January 2012
- journal article
- Published by Springer Science and Business Media LLC in Nutrition Journal
- Vol. 11 (1), 4
- https://doi.org/10.1186/1475-2891-11-4
Abstract
Bitter gourd (Momordica charantia L.) is a common tropical vegetable that has been used in traditional or folk medicine to treat diabetes. Wild bitter gourd (WBG) ameliorated metabolic syndrome (MetS) in animal models. We aimed to preliminarily evaluate the effect of WBG supplementation on MetS in Taiwanese adults. A preliminary open-label uncontrolled supplementation trial was conducted in eligible fulfilled the diagnosis of MetS from May 2008 to April 2009. A total of 42 eligible (21 men and 21 women) with a mean age of 45.7 ± 11.4 years (23 to 63 years) were supplemented with 4.8 gram lyophilized WBG powder in capsules daily for three months and were checked for MetS at enrollment and follow-up monthly. After supplementation was ceased, the participants were continually checked for MetS monthly over an additional three-month period. MetS incidence rate were analyzed using repeated-measures generalized linear mixed models according to the intention-to-treat principle. After adjusting for sex and age, the MetS incidence rate (standard error, p value) decreased by 7.1% (3.7%, 0.920), 9.5% (4.3%, 0.451), 19.0% (5.7%, 0.021), 16.7% (5.4%, 0.047), 11.9% (4.7%, 0.229) and 11.9% (4.7%, 0.229) at visit 2, 3, 4, 5, 6, and 7 compared to that at baseline (visit 1), respectively. The decrease in incidence rate was highest at the end of the three-month supplementation period and it was significantly different from that at baseline (p = 0.021). The difference remained significant at end of the 4th month (one month after the cessation of supplementation) (p = 0.047) but the effect diminished at the 5th and 6th months after baseline. The waist circumference also significantly decreased after the supplementation (p < 0.05). The WBG supplementation was generally well-tolerated. This is the first report to show that WBG improved MetS in human which provides a firm base for further randomized controlled trials to evaluate the efficacy of WBG supplementation.Keywords
This publication has 37 references indexed in Scilit:
- Bioactives from bitter melon enhance insulin signaling and modulate acyl carnitine content in skeletal muscle in high-fat diet-fed miceThe Journal of Nutritional Biochemistry, 2011
- Dietary Bitter Melon Seed Increases Peroxisome Proliferator-Activated Receptor-γ Gene Expression in Adipose Tissue, Down-Regulates the Nuclear Factor-κB Expression, and Alleviates the Symptoms Associated with Metabolic SyndromeJournal of Medicinal Food, 2011
- Persistent Increase of Prevalence of Metabolic Syndrome Among U.S. Adults: NHANES III to NHANES 1999–2006Diabetes Care, 2010
- Cucurbitane-Type Triterpenoids fromMomordica charantiaPlanta Medica, 2010
- Fruit extracts of Momordica charantia potentiate glucose uptake and up-regulate Glut-4, PPARγ and PI3KJournal of Ethnopharmacology, 2009
- C/EBPα and the Corepressors CtBP1 and CtBP2 Regulate Repression of Select Visceral White Adipose Genes during Induction of the Brown Phenotype in White Adipocytes by Peroxisome Proliferator-Activated Receptor γ AgonistsMolecular and Cellular Biology, 2009
- Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed ratsJournal of Ethnopharmacology, 2009
- Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat dietDiabetes Research and Clinical Practice, 2008
- Antidiabetic Activities of Triterpenoids Isolated from Bitter Melon Associated with Activation of the AMPK PathwayCell Chemical Biology, 2008
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005